Class summary at a glance.

Every drug in the Calculi Dissolution Agent class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 11tracked in Part D
CY24 Part D spend: —combined across class
Total Rx claims: —— unique beneficiaries
Generic mfrs (active): 0across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate

Brand: Anticoagulant Citrate Dextrose A · — Part D claims (CY24) · First FDA approval: 2003-08-26

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine

— Part D claims (CY24) · First FDA approval: 2009-12-14

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anticoagulant Citrate Dextrose (Acd)

Brand: ACD Blood-Pack Units (PL 146 PLASTIC) · — Part D claims (CY24) · First FDA approval: 2007-03-01

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anticoagulant Citrate Dextrose Solution Formula A

Brand: ACD-A · — Part D claims (CY24) · First FDA approval: 2007-03-01

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anticoagulant Citrate Phosphate Dextrose (Cpd)

Brand: Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic · — Part D claims (CY24) · First FDA approval: 2007-03-31

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anticoagulant Citrate Phosphate Dextrose (Cpd) Solution

Brand: Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic · — Part D claims (CY24) · First FDA approval: 2007-03-01

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Anticoagulant Citrate Phosphate Dextrose Adenine

Brand: CPDA-1 · — Part D claims (CY24) · First FDA approval: 2007-03-01

Brand-only (no generics)

Low NADAC—